Drug overdose deaths among homeless veterans in the United States Department of Veterans Affairs healthcare system.

death homeless person homicide overdose suicide unintentional veteran

Journal

Addiction (Abingdon, England)

ISSN: 1360-0443

Titre abrégé: Addiction

Pays: England

ID NLM: 9304118

Informations de publication

Date de publication:
17 Oct 2024

Historique:

received: 05 05 2024

accepted: 19 09 2024

medline: 17 10 2024

pubmed: 17 10 2024

entrez: 17 10 2024

Statut: aheadofprint

Résumé

With an epidemic of drug overdoses, contemporary research is needed to examine drug overdose deaths among homeless populations. This study measured rates, types and correlates of drug overdose deaths occurring over a 5-year study period among veterans experiencing homelessness (VEH) and non-homeless veterans (NHV) in the US Department of Veterans Affairs (VA) healthcare system. Retrospective cohort study. USA. A total of 6 128 921 veterans. We followed 399 125 VEH and 5 729 796 NHV between 2017 and 2021 using linked administrative VA and National Death Index data. Multivariable Cox regression models were constructed to estimate hazard ratios (HRs) for homelessness as a predictor of time-to-occurrence of overdose deaths with 95% confidence interval (CIs), sequentially controlling for demographic, medical, substance use and mental health characteristics. Among overdose deaths, 8653 [93.7%, 95% confidence interval (CI) = 93.2-94.2%] were unintentional and 5378 (57.8%, 95% CI = 56.8-58.8%) involved opioids. The overdose-specific mortality rate (per 100 000 person-years) was 227.3 among VEH and 23.2 among NHV (HR = 9.76, 95% CI = 9.36, 10.16), with rates 7-14 times higher among VEH than NHV, depending on the drug involved. In fully adjusted models, homelessness was associated with greater risk of drug overdose death (HR = 3.33, 95% CI = 3.18, 3.49), with the greatest risk involving psychostimulants (HR = 4.19), followed by antiepileptic/sedative/hypnotic drugs (HR = 3.69), synthetic opioids (HR = 3.50) and natural and semi-synthetic opioids (HR = 2.79). US veterans experiencing homelessness appear to have three times the risk for drug overdose deaths than non-homeless veterans. There may be specific risks associated with psychostimulant, antiepileptic, sedative and hypnotic drugs in this population that deserve greater attention.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE

DESIGN METHODS

Retrospective cohort study.

SETTING METHODS

USA.

PARTICIPANTS METHODS

A total of 6 128 921 veterans. We followed 399 125 VEH and 5 729 796 NHV between 2017 and 2021 using linked administrative VA and National Death Index data.

MEASUREMENTS METHODS

Multivariable Cox regression models were constructed to estimate hazard ratios (HRs) for homelessness as a predictor of time-to-occurrence of overdose deaths with 95% confidence interval (CIs), sequentially controlling for demographic, medical, substance use and mental health characteristics.

FINDINGS RESULTS

Among overdose deaths, 8653 [93.7%, 95% confidence interval (CI) = 93.2-94.2%] were unintentional and 5378 (57.8%, 95% CI = 56.8-58.8%) involved opioids. The overdose-specific mortality rate (per 100 000 person-years) was 227.3 among VEH and 23.2 among NHV (HR = 9.76, 95% CI = 9.36, 10.16), with rates 7-14 times higher among VEH than NHV, depending on the drug involved. In fully adjusted models, homelessness was associated with greater risk of drug overdose death (HR = 3.33, 95% CI = 3.18, 3.49), with the greatest risk involving psychostimulants (HR = 4.19), followed by antiepileptic/sedative/hypnotic drugs (HR = 3.69), synthetic opioids (HR = 3.50) and natural and semi-synthetic opioids (HR = 2.79).

CONCLUSIONS CONCLUSIONS

US veterans experiencing homelessness appear to have three times the risk for drug overdose deaths than non-homeless veterans. There may be specific risks associated with psychostimulant, antiepileptic, sedative and hypnotic drugs in this population that deserve greater attention.

Identifiants

DOI: 10.1111/add.16689 PMID: 39415621

pubmed: 39415621

doi: 10.1111/add.16689

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Subventions

Organisme : U.S. Department of Veterans Affairs

Organisme : VA

Pays : United States

Informations de copyright

Published 2024. This article is a U.S. Government work and is in the public domain in the USA.

Références

Aldridge RW, Story A, Hwang SW, Nordentoft M, Luchenski SA, Hartwell G, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high‐income countries: a systematic review and meta‐analysis. Lancet. 2018;391(10117):241–250. https://doi.org/10.1016/S0140-6736(17)31869-X

Fazel S, Geddes JR, Kushel M. The health of homeless people in high‐income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations. Lancet. 2014;384(9953):1529–1540. https://doi.org/10.1016/S0140-6736(14)61132-6

Roberts E, Copeland C, Humphreys K, Shover CL. Drug‐related deaths among housed and homeless individuals in the UK and the USA: comparative retrospective cohort study. Br J Psychiatry. 2023;223(6):562–568. https://doi.org/10.1192/bjp.2023.111

Fischer B, Pang M, Tyndall M. The opioid death crisis in Canada: crucial lessons for public health. Lancet Public Health. 2019;4(2):e81–e82. https://doi.org/10.1016/S2468-2667(18)30232-9

Friedman J, Gjersing L. Increases in drug overdose deaths in Norway and the United States during the COVID‐19 pandemic. Scand J Public Health. 2023;51(1):53–57. https://doi.org/10.1177/14034948221075025

Snowdon J. Drug overdose death rates in different countries: who should be alarmed? Australas Psychiatry. 2022;30(1):26–30. https://doi.org/10.1177/10398562221075192

Jalal H, Buchanich JM, Roberts MS, Balmert LC, Zhang K, Burke DS. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science. 2018;361(6408):eaau1184. https://doi.org/10.1126/science.aau1184

Tsai J, Kasprow WJ, Rosenheck RA. Alcohol and drug use disorders among homeless veterans: prevalence and association with supported housing outcomes. Addict Behav. 2014;39(2):455–460. https://doi.org/10.1016/j.addbeh.2013.02.002

Fine DR, Dickins KA, Adams LD, De Las Nueces D, Weinstock K, Wright J, et al. Drug overdose mortality among people experiencing homelessness, 2003 to 2018. JAMA Netw Open. 2022;5(1):e2142676. https://doi.org/10.1001/jamanetworkopen.2021.42676

Baggett TP, Hwang SW, O'Connell JJ, Porneala BC, Stringfellow EJ, Orav EJ, et al. Mortality among homeless adults in Boston: shifts in causes of death over a 15‐year period. JAMA Intern Med. 2013;173(3):189–195. https://doi.org/10.1001/jamainternmed.2013.1604

Tsai J, Rosenheck RA. US Veterans' use of VA mental health services and disability compensation increased from 2001 to 2010. Health Aff (Millwood). 2016;35(6):966–973. https://doi.org/10.1377/hlthaff.2015.1555

Tsai J, Pietrzak RH, Szymkowiak D. The problem of veteran homelessness: an update for the new decade. Am J Prev Med. 2021;60(6):774–780. https://doi.org/10.1016/j.amepre.2020.12.012

Jasuja GK, Bettano A, Smelson D, Bernson D, Rose AJ, Byrne T, et al. Homelessness and veteran status in relation to nonfatal and fatal opioid overdose in Massachusetts. Med Care. 2021;59(Suppl 2):S165–S169. https://doi.org/10.1097/MLR.0000000000001437

Riggs KR, Hoge AE, DeRussy AJ, Montgomery AE, Holmes SK, Austin EL, et al. Prevalence of and risk factors associated with nonfatal overdose among veterans who have experienced homelessness. JAMA Netw Open. 2020;3(3):e201190. https://doi.org/10.1001/jamanetworkopen.2020.1190

Tsai J, Szymkowiak D, Jutkowitz E. Developing an operational definition of housing instability and homelessness in veterans health Administration's medical records. PLoS ONE. 2022;17(12):e0279973. https://doi.org/10.1371/journal.pone.0279973

Hedegaard H, Minino AM, Spencer MR, Warner M. Drug overdose deaths in the United States, 1999‐2020. NCHS Data Brief. 2021;426:1–8.

Spencer MR, Minino AM, Warner M. Drug overdose deaths in the United States, 2001‐2021. NCHS Data Brief. 2022;457:1–8.

Koh KA, Szymkowiak D, Tsai J. Benzodiazepine prescriptions for homeless veterans affairs service users with mental illness. Psychiatr Serv. 2023;appips20220472.

Kariisa M, O'Donnell J, Kumar S, Mattson CL, Goldberger BA. Illicitly manufactured fentanyl‐involved overdose deaths with detected xylazine ‐ United States, January 2019‐June 2022. MMWR Morb Mortal Wkly Rep. 2023;72(26):721–727. https://doi.org/10.15585/mmwr.mm7226a4

Delcher C, Anthony N, Mir M. Xylazine‐involved fatal overdoses and localized geographic clustering: Cook County, IL, 2019‐2022. Drug Alcohol Depend. 2023;249:110833. https://doi.org/10.1016/j.drugalcdep.2023.110833

Parpouchi M, Moniruzzaman A, Rezansoff SN, Russolillo A, Somers JM. Characteristics of adherence to methadone maintenance treatment over a 15‐year period among homeless adults experiencing mental illness. Addict Behav Rep. 2017;6:106–111. https://doi.org/10.1016/j.abrep.2017.09.001

Iheanacho T, Payne K, Tsai J. Mobile, community‐based buprenorphine treatment for veterans experiencing homelessness with opioid use disorder: a pilot, feasibility study. Am J Addict. 2020;29(6):485–491. https://doi.org/10.1111/ajad.13055

Parpouchi M, Moniruzzaman A, Rezansoff SN, Russolillo A, Somers JM. The effect of housing first on adherence to methadone maintenance treatment. Int J Drug Policy. 2018;56:73–80. https://doi.org/10.1016/j.drugpo.2018.03.012

Love JS, Levine M, Aldy K, Brent J, Krotulski AJ, Logan BK, et al. Opioid overdoses involving xylazine in emergency department patients: a multicenter study. Clin Toxicol (Phila). 2023;61(3):173–180. https://doi.org/10.1080/15563650.2022.2159427

Collins AB, Wightman RS, Macon EC, Guan Y, Shihipar A, Krieger M, et al. Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island. Int J Drug Policy. 2023;118:104118. https://doi.org/10.1016/j.drugpo.2023.104118

Bauer LK, Brody JK, Leon C, Baggett TP. Characteristics of homeless adults who died of drug overdose: a retrospective record review. J Health Care Poor Underserved. 2016;27(2):846–859. https://doi.org/10.1353/hpu.2016.0075

Harruff RC, Yarid NA, Barbour WL, Martin YH. Medical examiner response to the drug overdose epidemic in King County Washington: “real‐time“ surveillance, data science, and applied forensic epidemiology. J Forensic Sci. 2023;68(5):1632–1642. https://doi.org/10.1111/1556-4029.15329

Marshall JR, Gassner SF, Anderson CL, Cooper RJ, Lotfipour S, Chakravarthy B. Socioeconomic and geographical disparities in prescription and illicit opioid‐related overdose deaths in Orange County, California, from 2010‐2014. Subst Abus. 2019;40(1):80–86. https://doi.org/10.1080/08897077.2018.1442899

Richer I, Bertrand K, Vandermeerschen J, Roy E. A prospective cohort study of non‐fatal accidental overdose among street youth: the link with suicidal ideation. Drug Alcohol Rev. 2013;32(4):398–404. https://doi.org/10.1111/dar.12003

Darke S, Duflou J, Peacock A, Farrell M, Lappin J. A descriptive coronial study of heroin toxicity deaths in Australia, 2020‐2022: characteristics, toxicology and survival times. Addiction. 2024;119(3):559–569. https://doi.org/10.1111/add.16377

Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, et al. Predictors of non‐fatal overdose among a cohort of polysubstance‐using injection drug users. Drug Alcohol Depend. 2007;87(1):39–45. https://doi.org/10.1016/j.drugalcdep.2006.07.009

Klee H, Morris J. Factors that characterize street injectors. Addiction. 1995;90(6):837–841. https://doi.org/10.1111/j.1360-0443.1995.tb02233.x

Leelakanok N, Holcombe AL, Lund BC, Gu X, Schweizer ML. Association between polypharmacy and death: a systematic review and meta‐analysis. J Am Pharm Assoc (2003). 2017;57(6):729–38 e10. https://doi.org/10.1016/j.japh.2017.06.002

Konefal S, Sherk A, Maloney‐Hall B, Young M, Kent P, Biggar E. Polysubstance use poisoning deaths in Canada: an analysis of trends from 2014 to 2017 using mortality data. BMC Public Health. 2022;22(1):269. https://doi.org/10.1186/s12889-022-12678-z